Our leadership brings deep industry experience from leading biopharma and biotech companies — applied directly to your program
Strategically located in Natick's Innovation District near major biotech hubs, providing unparalleled access to cutting-edge resources and talent in the heart of the Boston/Cambridge life sciences ecosystem.
We deliver rigorous science, transparent communication, and rapid turnaround — so your therapeutic programs move forward without compromise
Fully transparent partnership model tailored to your specific research needs.
Rapid data turnaround with comprehensive analysis and ongoing communication.
Scientific rigor with built-in course correction. No restarts, no wasted cycles.
More affordable than large CRO corporations without sacrificing quality.
Focusing on translating preclinical research into clinical results:
Cell line engineering (random integration or targeted insertion) with clone isolation and characterization
Design, development, and execution of cell-based reporter assays
Gene knockdown (siRNA, shRNA, ASOs) and gene knockout (CRISPR)
cDNA design, overexpression, and gene rescue
Transfection (lipofection, nucleofection) and transduction (retrovirus, lentivirus) with titer determination
Cell viability/CTG assays, apoptosis, and cell cycle analysis
Small molecule IC50, and derivation of drug-resistant cell lines for MoR
DNA cloning, RNA isolation/QC, and qPCR
NGS library preparation
Protein quantification, Western blot, ELISA, and flow cytometry
Immunofluorescence, immunoprecipitation, and protein complex purification
Recombinant protein techniques, GST pulldown, and EMSA
Customized iPSC line reprogramming, purification, characterization, and cryobanking
iPSC expansion in 3D culture and differentiation platforms
CGT product function validation via in vitro cellular, biochemical, and molecular assays
Ready to request a quote, or simply have questions?
Send us an email at contact@immuneaxis.com.